Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
State Street SPDR S&P Biotech ETF
(NY:
XBI
)
153.91
+4.62 (+3.10%)
Delayed Quote
Updated: 2:06 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about State Street SPDR S&P Biotech ETF
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
How Are Biotech ETFs Reacting To These Q3 Earnings Releases?
↗
November 06, 2021
There's no denying that the pandemic has opened up investment opportunities in the biotech sector by triggering a race to introduce vaccines. Let’s take a look at big biotech earnings releases to see...
Via
Talk Markets
Wednesdays With Wedbush On PreMarket Prep Plus
↗
November 03, 2021
On the PreMarket Prep Plus "Wednesday’s With Wedbush" segment, Sahak Manuelian, managing director and head of equi...
Via
Benzinga
15 Charts All Traders Should Look At Every Morning
↗
September 30, 2021
One of the hardest things to do as a day trader is gathering all the necessary information to execute profitable trades. Below are the to...
Via
Benzinga
Look For The Q4 Biotech Bounce In Mid-Small Caps
↗
September 17, 2021
Large-cap biopharma stocks are off their highs because of prospects that drug prices may be directly negotiated through Medicare but several Democrats are not in agreement as to how this could be best...
Via
Talk Markets
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity
↗
August 11, 2021
SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares...
Via
Benzinga
Topics
Stocks
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity
↗
August 09, 2021
SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares...
Via
Benzinga
Topics
Stocks
Unusual Options Activity Insight: SPDR Series Trust SPDR S&P Biotech ETF
↗
August 06, 2021
On Friday, shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:
Via
Benzinga
Topics
Stocks
Understanding SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity
↗
August 03, 2021
Shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI
Via
Benzinga
Topics
Stocks
Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market
↗
September 09, 2021
Despite record highs in the Nasdaq recently at the 15,000 level the biotech market seems sluggish. Speculation has ebbed. As if we need a green screen every day.
Via
Talk Markets
Healthcare Stocks Hit New Highs but Small Caps Lag
↗
August 23, 2021
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field.
Via
Talk Markets
ETF Reflections: US Stocks
↗
August 21, 2021
I'm a bear. So the longer they prop this dreck up, the greater the fall. Suits me!
Via
Talk Markets
Biotech ETFs To Benefit From Latest Booster Update
↗
August 21, 2021
Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from...
Via
Talk Markets
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity
↗
August 16, 2021
On Monday, shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) saw unusual options activity. After the option alert, the stock price moved down to $122.44. Sentiment...
Via
Benzinga
Topics
Stocks
Unusual Options Activity Insight: SPDR Series Trust SPDR S&P Biotech ETF
↗
July 30, 2021
SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares...
Via
Benzinga
Topics
Stocks
Large Cap Biopharma Stocks provide Growth and Value
↗
August 16, 2021
The S&P 500 Healthcare Index was up 0.53% and biotech still lags in healthcare yet Large Cap Biopharma is doing well YTD.
Via
Talk Markets
Topics
Stocks
ETF Investing Areas to Consider for August
↗
August 09, 2021
There is no doubt that the second-quarter 2021 earnings season is going strong.
Via
Talk Markets
Carter Worth And Mike Khouw's XBI Trade
↗
August 08, 2021
On CNBC's "Options Action," Carter Worth of Cornerstone Macro said SPDR S&P Biotech ETF (NYSE: XBI) has a bounce potential, having sold off to support. XBI is an...
Via
Benzinga
Topics
Stocks
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity
↗
July 27, 2021
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity Shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE: XBI) saw some unusual options activity...
Via
Benzinga
Topics
Stocks
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity
↗
July 15, 2021
On Thursday, shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) saw unusual options activity. After the option alert, the stock price moved up to $126.24. Sentiment...
Via
Benzinga
Topics
Stocks
Understanding SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity
↗
July 12, 2021
Shares of SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $132...
Via
Benzinga
Topics
Stocks
Mid-Cap Biotech Picks: Seasonal Rally Underway
↗
July 03, 2021
Many Mid-Cap biotech stocks were hit hard after the February peak. We suggest three new mid-cap biotech picks. All three picks can be volatile but very tradable.
Via
Talk Markets
IBB Vs. XBI: Which Biotech ETF Has A Better Chart?
↗
June 30, 2021
The SPDR S&P Biotech ETF XBI is trading below an important resistance level, but the iShares Nasdaq Biotechnology ETF IBB has broken out.
Via
Talk Markets
Topics
Stocks
IBB Vs. XBI: Which Biotech ETF Has A Better Chart?
↗
June 30, 2021
The SPDR S&P Biotech ETF (NYSE: XBI) is trading below an important resistance level, but the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) has broken out. Resistance is a...
Via
Benzinga
Topics
Stocks
Why Regeneron Pharmaceuticals Analyst Says Competitive Concerns Are Overblown, Pipeline Opportunity Underappreciated
↗
June 29, 2021
Regeneron Pharmaceuticals Inc.'s (NASDAQ:REGN) robust ...
Via
Benzinga
Healthcare Portfolio Playbook: Time To Rebalance With MedTech
↗
June 18, 2021
As we look to re-balance our portfolio in the near-term, investors should consider adding Medtech as we have suggested in the past. Though, more recently, we have also focused on large-cap...
Via
Talk Markets
Should You Buy Biotech ETFs Now?
↗
June 16, 2021
Instead of trying to pick winners in this volatile space, it is better to invest in broader biotech ETFs that stand to benefit from increased investor interest and rising spending on drugs and...
Via
Talk Markets
Tuesday Talk: Action!
↗
June 15, 2021
U.S. stock markets started the week in continued action mode. The S&P 500 closed at 4,255, up nearly 8 points, the Dow closed at 34,394, down 85 points and the Nasdaq Composite closed at 14,174, up...
Via
Talk Markets
Topics
Stocks
Biotechs Ready To Roar
↗
June 13, 2021
The biggest event last week was the FDA decision to approve Biogen's drug aducanumab, a treatment for Alzheimer's disease. The decision will reverberate across the industry and the healthcare sector...
Via
Talk Markets
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort
↗
June 13, 2021
In a sector where picking individual stocks is a high-risk, high-reward strategy, the diversification of exchange-traded funds can be highly appealing.
Via
The Motley Fool
Analyzing SPDR Series Trust SPDR S&P Biotech ETF's Unusual Options Activity
↗
June 11, 2021
SPDR Series Trust SPDR S&P Biotech ETF (NYSE:XBI) shares experienced unusual options activity on Friday. The stock price moved up to $136.19 following the option alert....
Via
Benzinga
Topics
Stocks
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
